Keizo Sugasawa

This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Astellas Pharma Gmbh, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2003-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keizo Sugasawa. Retrieved from https://idiyas.com/inventor/keizo-sugasawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 2)

% Patents Active = 26.7

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 8.7

ph-index = 5

Forward Citations = 77(Granted Patents)

Location History:

Ibaraki, JP (2005 - 2007)
Tsukuba, JP (2003 - 2012)
Tokyo, JP (2008 - 2019)

Company Filing History:

Yamanouchi Pharmaceutical Company Ltd.

patents

Years Active: 2003-2019

Loading Chart...

Areas of Expertise:

Piperazine Derivative

Acylaminothiazole

Azolecarboxamide

Diazepan Derivatives

Substituted Benzene

Pyrazole Derivative

Pharmaceutical Composition

Chemical Synthesis

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10301286 - Piperazine derivative (2019-05-28),

2. 8765764 - 2-acylaminothiazole derivative or salt thereof (2014-07-01),

3. 8338429 - 2-acylaminothiazole derivative or salt thereof (2012-12-25),

4. 8304547 - Azolecarboxamide compound or salt thereof (2012-11-06),

5. RE43481 - Diazepan derivatives or salts thereof (2012-06-18),

6. 8163746 - Azolecarboxamide derivative (2012-04-24),

7. 7786106 - Substituted benzene derivatives or salts thereof (2010-08-31),

8. 7638536 - 2-Acylaminothiazole derivative or salt thereof (2009-12-29),

9. 7504417 - Substituted benzene derivatives or salts thereof (2009-03-17),

10. 7361658 - 2-acylaminothiazole derivative or salt thereof (2008-04-22),

11. 7307074 - Diazepan derivatives or salts thereof (2007-12-11),

12. 7285554 - Pyrazole derivative (2007-10-23),

13. 7247635 - Pyrazole derivative (2007-07-24),

14. 6958339 - Pyrazole derivative (2005-10-25),

15. 6642224 - Diazepan derivatives or salts thereof (2003-11-04),

Title: The Innovative Contributions of Keizo Sugasawa

Introduction

Keizo Sugasawa is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, Sugasawa has made remarkable advancements in the development of compounds that address various medical conditions.

Latest Patents

One of Sugasawa's latest patents involves a piperazine derivative, which serves as an MCreceptor agonist. This compound has been identified as having potential applications in preventing or treating bladder and urinary tract diseases, including underactive bladder and voiding dysfunctions associated with benign prostatic hyperplasia. Another notable patent is for a 2-acylaminothiazole derivative, which has shown excellent effects in proliferating human c-mpl-Ba/F3 cells and increasing platelet counts, making it useful in treating thrombocytopenia.

Career Highlights

Throughout his career, Sugasawa has worked with leading pharmaceutical companies, including Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd. His work has been instrumental in advancing therapeutic options for patients suffering from various conditions.

Collaborations

Sugasawa has collaborated with notable colleagues such as Fukushi Hirayama and Yuji Koga. These partnerships have fostered innovation and have contributed to the successful development of his patented compounds.

Conclusion

Profile summary based on public USPTO records.